Risk factors and outcomes in patients undergoing minimally invasive hepatectomy with unplanned conversion: a contemporary NSQIP analysis

Vining, Charles C.; Abbas, Amr I. Al; Kuchta, Kristine; Paterakos, Pierce; Choi, Sung Hoon; Talamonti, Mark S.; Hogg, Melissa E.

doi:10.1016/j.hpb.2023.01.018

Cited by 8 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Conclusions from retrospective studies and meta‐analyses comparing RH to LH are more variable. For perioperative outcomes, RH requires a longer operative time but is consistently associated with a lower conversion rate than LH ( p < 0.001) 109–112 . In most other surgical procedures, a robotic approach is associated with decreased operative blood loss compared to a laparoscopic approach.…”

Section: Hepato‐pancreato‐biliary Surgerymentioning

confidence: 99%

“…For perioperative outcomes, RH requires a longer operative time but is consistently associated with a lower conversion rate than LH (p < 0.001). [109][110][111][112] In most other surgical procedures, a robotic approach is associated with decreased operative blood loss compared to a laparoscopic approach. However, because there is currently no robotic Cavitron ® Ultrasonic Surgical Aspirator (CUSA) (Integra LifeSciences, Tullamore, Ireland), RH is mainly performed using the crush clamp technique, thus leading to higher operative blood loss.…”

Section: Robotic Versus Laparoscopic Hepatectomymentioning

confidence: 99%

See 1 more Smart Citation

Prince and princesses: The current status of robotic surgery in surgical oncology

Hays,

Corvino,

Lorié

et al. 2023

Journal of Surgical Oncology

Self Cite

View full text Add to dashboard Cite

Robotic surgery has experienced a dramatic increase in utilization across general surgery over the last two decades, including in surgical oncology. Although urologists and gynecologists were the first to show that this technology could be utilized in cancer surgery, the robot is now a powerful tool in the treatment of gastrointestinal, hepato–pancreatico–biliary, colorectal, endocrine, and soft tissue malignancies. While long‐term outcomes are still pending, short‐term outcomes have showed promise for this technologic advancement of cancer surgery.

show abstract

Section: Hepato‐pancreato‐biliary Surgerymentioning

confidence: 99%